When did CytomX Therapeutics report Q4 2024 earnings?

CytomX Therapeutics (CTMX) reported Q4 2024 earnings on March 6, 2025 after market close.

What were CytomX Therapeutics's Q4 2024 revenue and EPS?

CytomX Therapeutics reported revenue of $38.1M and eps of $0.22 for Q4 2024.

Did CytomX Therapeutics beat estimates in Q4 2024?

Revenue beat the consensus estimate of $13.0M by $25.1M. EPS beat the consensus estimate of $-0.23 by $0.45.

Where can I find CytomX Therapeutics's Q4 2024 SEC filings?

You can read the 10-K periodic report (0000950170-25-034575) directly on SEC EDGAR. The filing index links above go to sec.gov.

CytomX Therapeutics CTMX Q4 2024 Annual earnings

Reported March 6, 2025 · After market close

Revenue$38.1MBeat by $25.1M

EPS$0.22Beat by $0.45

Revenue estimate$13.0M

EPS estimate-$0.23

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$12.4M

EPS estimate-$0.11

Financials

Q4 2024

Income statement

See full

Revenue$38.1M+43.2%

Operating income$17.7M+3,017%

Net income$18.9M—

EPS (diluted)$0.23—

Balance sheet

See full

Cash & equivalents$38.1M+122%

Total debt$9.4M-32.8%

Total equity-$456.0K+99.0%

Total assets$120.5M-40.3%

Cash flow

See full

Operating cash flow-$19.9M+9.4%

CapEx$80.0K-69.9%

Free cash flow-$20.0M+10.1%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$80.61M-22.4%

Enterprise value$51.94M-48.4%

P/E2.5×—

P/S0.6×-0.4×

Profitability

See full

Operating margin18.1%+14.3pp

Net margin23.1%—

FCF margin-62.7%+8.2pp

Returns & leverage

See full

Current ratio1.3×+0.1×

Versus estimates

Revenue

Q1 2026$10.3MBeat by $5.6M Q4 2025$661.0KMiss by $6.7M Q3 2025$6.0MMiss by $1.4M Q2 2025$18.7MBeat by $378.0K Q1 2025$50.9MBeat by $15.5M

Q4 2024$38.1MBeat by $25.1M

Diluted EPS

Q1 2026-$0.10Beat by $0.04 Q4 2025-$0.22Miss by $0.14 Q3 2025-$0.09Miss by $0.04 Q2 2025-$0.00Beat by $0.06 Q1 2025$0.27Beat by $0.15

Q4 2024$0.22Beat by $0.45

Ask the moment CytomX Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did CytomX Therapeutics report Q4 2024 earnings?: CytomX Therapeutics (CTMX) reported Q4 2024 earnings on March 6, 2025 after market close.
What were CytomX Therapeutics's Q4 2024 revenue and EPS?: CytomX Therapeutics reported revenue of $38.1M and eps of $0.22 for Q4 2024.
Did CytomX Therapeutics beat estimates in Q4 2024?: Revenue beat the consensus estimate of $13.0M by $25.1M. EPS beat the consensus estimate of $-0.23 by $0.45.
Where can I find CytomX Therapeutics's Q4 2024 SEC filings?: You can read the 10-K periodic report (0000950170-25-034575) directly on SEC EDGAR. The filing index links above go to sec.gov.